Serena Silver Email and Phone Number
Serena Silver work email
- Valid
- Valid
Serena Silver personal email
Innovative and creative scientific leader, skilled in strategic planning, complex collaborations, and building diverse teams to enable effective experimental design, implementation, and analysis; Expertise across the drug discovery process, from Target Discovery and Validation to in vivo pharmacology and translational research; Proven leadership in portfolio strategy, disease selection and portfolio prioritization; Key player in multiple highly productive scientific and strategic partnerships with industry and academia; Deep expertise in biology platforms to accelerate drug discovery for cancer biology and rare disease; broad experience with RNAi, CRISPR and chemical genetics, disease model building, and pharmacology.
Accent Therapeutics, Inc.
View- Website:
- accenttx.com
- Employees:
- 33
-
Chief Scientific OfficerAccent Therapeutics, Inc.Cambridge, Ma, Us
-
Vice President Of BiologyAccent Therapeutics, Inc. Sep 2022 - PresentLexington, Massachusetts, Us
-
Vice President, Discovery Biology & TechnologiesFulcrum Therapeutics Jul 2021 - Aug 2022Head of Discovery Biology & Technologies organization, including Target Discovery, Cell Biology and Target Validation, cell assays for lead optimization, in vivo pharmacology, and technology platforms for target and drug discovery (lab automation, imaging, RNAseq and scRNAseq). Managed biology resources and budget to drive drug discovery.
-
Senior Director, Discovery BiologyFulcrum Therapeutics Jul 2020 - Jun 2021
-
Director, Discovery BiologyFulcrum Therapeutics Apr 2019 - Jul 2020
-
Senior Investigator Ii, Head Of Molecular PharmacologyNovartis Institutes For Biomedical Research Sep 2017 - Apr 2019Basel, Baselstadt, ChDirected a multidisciplinary department focused on novel assay development to interrogate cancer target biology, and to enable drug discovery and indication expansion. As a member of Oncology Drug Discovery Leadership team (ODD-LT), contributed to portfolio review, strategic planning for new areas of focus, and decision making around resourcing and prioritization. -
Senior Investigator I, Head Of Molecular PharmacologyNovartis Institutes For Biomedical Research Nov 2013 - Nov 2017Basel, Baselstadt, Ch
-
Lead Research Investigator, Section Head Target DiscoverySanofi Mar 2013 - Oct 2013Paris, France, FrLed development and maintenance of a robust early pipeline for Sanofi Oncology. Managed initiatives of the Target ID and Validation group in a highly matrixed environment. -
Principal Research InvestigatorSanofi Mar 2011 - Mar 2013Paris, France, FrHead of research team which conducted and analyzed functional genomics and chemical screens, as single agents and in combination, to identify new targets and expand indications for existing molecules in Sanofi pipeline.
-
Group Leader, Rnai Screening ProjectsBroad Institute May 2006 - Mar 2011Cambridge, Ma, UsGroup leader within the RNAi Platform to design and execute large scale RNAi screens in mammalian tissue culture using lentivirus-based shRNA library, collaborating across diverse project areas, including cancer research, infectious disease, and metabolic disease. -
Postdoctoral FellowHarvard Medical School May 2004 - May 2006Boston, Ma, UsPrimary Project: Identify and characterize the role of miRNAs in Signal Transduction networks. Utilized cell-based assays to screen miRNAs for cellular function and validated findings in vivo; led to identification of miR-315 as a potent activator of Wnt signaling.Secondary Project: Determine the extent and nature of “off-target” effects in the Drosophila RNAi Screening Center (DRSC) dsRNA collection through analysis of data from over 40 genome-wide RNAi screens in Drosophila cells. -
Graduate StudentMit 1999 - 2004Cambridge, Ma, UsInvestigation of the effects of Ras/MAPK signaling on the transcription factor EYES ABSENT, and demonstration that this protein also functions as a novel protein tyrosine phosphatase. -
Graduate StudentWhitehead Institute 1999 - 2004
Serena Silver Skills
Serena Silver Education Details
-
Massachusetts Institute Of TechnologyBiology -
New York University
-
New York UniversityEnglish & American Literature
Frequently Asked Questions about Serena Silver
What company does Serena Silver work for?
Serena Silver works for Accent Therapeutics, Inc.
What is Serena Silver's role at the current company?
Serena Silver's current role is Chief Scientific Officer.
What is Serena Silver's email address?
Serena Silver's email address is ss****@****mit.edu
What schools did Serena Silver attend?
Serena Silver attended Massachusetts Institute Of Technology, New York University, New York University.
What skills is Serena Silver known for?
Serena Silver has skills like Molecular Biology, High Throughput Screening, Assay Development, Cell Biology, Drug Discovery, Biochemistry, Genomics, Rnai, Genetics, Cell, Cell Culture, Cancer.
Who are Serena Silver's colleagues?
Serena Silver's colleagues are Gordon J Lockbaum, Shihua Yao, David Brennan, Taylor Hotz, Kevin Mcgann.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial